Behind the science
‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it
Antibiotics are the cornerstone of modern medicine, treating everyday as well as serious infections. As bacteria evolve to outsmart antibiotics, proactive action will play a critical role in slowing the march of drug-resistant infections.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Behind the science